Literature DB >> 2986526

Axonal attenuation and secondary segmental demyelination in myeloma neuropathies.

T Ohi, R A Kyle, P J Dyck.   

Abstract

The sural nerves of 5 patients with osteosclerotic myeloma and polyneuropathy, of 3 patients with multiple myeloma and polyneuropathy, and of 6 healthy subjects were studied by neuropathological, morphometric, and teased-fiber approaches to assess cellular (Schwann cell or axon) vulnerability and to explore the mechanism of segmental demyelination. As compared with controls, the nerves of both types of myeloma neuropathy demonstrated a statistically significant and marked loss of myelinated fibers and increased frequencies of axonal degeneration among teased fibers at statistically significant levels. The peaks of diameter histograms of myelinated fibers of osteosclerotic myeloma/polyneuropathy nerves were displaced to smaller diameter categories, suggesting fiber atrophy. Segmental demyelination and remyelination was clustered, as found in secondary demyelination. Large- and intermediate-diameter myelinated fibers of osteosclerotic myeloma/polyneuropathy nerves had significantly smaller axon calibers relative to myelin spiral length seen in electron micrographs. The loss of myelinated fiber axons, the shift of the peaks of diameter histograms to smaller sizes, the lack of noticeable increased numbers of demyelinated axons, the clustered distribution of segmental demyelination, and the axonal attenuation suggest a special axonal or neuronal vulnerability and appear to provide an explanation for the observed segmental demyelination. Whether axonal attenuation has a perikaryeal or proximal axonal genesis now needs to be determined.

Entities:  

Mesh:

Year:  1985        PMID: 2986526     DOI: 10.1002/ana.410170306

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Patterns of morphological variation within myelin internodes of normal peripheral nerve: quantitative analysis by confocal microscopy.

Authors:  R J Reynolds; J W Heath
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

2.  Case report 572. Osteosclerotic myeloma (POEMS) syndrome.

Authors:  C Brandon; W Martel; L Weatherbee; P Capek
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

3.  Adaptation of the myelin sheath during axonal atrophy.

Authors:  J H O'Neill; R W Gilliatt
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Pathological findings in three non-Japanese patients with the POEMS syndrome.

Authors:  R Gherardi; M Baudrimont; M Kujas; D Malapert; F Lange; F Gray; J Poirier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

5.  Morphological changes in IgM paraproteinaemic neuropathy.

Authors:  J M Jacobs; J W Scadding
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Rapid quantitative immunohistochemical assessment of human peripheral neuropathies using a monoclonal antibody against nerve growth factor receptor.

Authors:  E Scarpini; S Beretta; A H Ross; M Moggio; S Jann; D Pleasure; G Scarlato
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

7.  Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case.

Authors:  G Sobue; M Doyu; M Watanabe; F Hayashi; T Mitsuma
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Smaller axon and unaltered numbers of microtubules per axon in relation to number of myelin lamellae of myelinated fibers in the mutant quail deficient in neurofilaments.

Authors:  J X Zhao; A Ohnishi; C Itakura; M Mizutani; T Yamamoto; T Hojo; Y Murai
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Susceptibility to pressure neuropathy distal to a constricting ligature in the guinea-pig.

Authors:  T Shimpo; R W Gilliatt; R P Kennett; P J Allen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

10.  Peripheral neuropathy in essential mixed cryoglobulinaemia.

Authors:  F Gemignani; G Pavesi; A Fiocchi; P Manganelli; G Ferraccioli; A Marbini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.